Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ETX.L (ETX) Share News

e-Therapeutics Loss Widens As It Continues Pipeline Development

12th May 2014 11:49

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e Read More

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

8th May 2014 13:30

LONDON (Alliance News) - British gas parent <strong>Centrica</strong> has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians Read More

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

8th May 2014 12:23

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br />-------<br />FTSE 100 - WINNERS<br />-------<br /><strong>Barclays</strong>, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round Read More

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

8th May 2014 10:51

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui Read More

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

7th Apr 2014 12:25

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl Read More

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

7th Apr 2014 10:57

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com Read More

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

31st Mar 2014 12:50

LONDON (Alliance News) - <strong>Babcock International Group</strong> is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.<br /><br />The joint venture with Fluo Read More

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

31st Mar 2014 12:45

LONDON (Alliance News) - <strong>Babcock International Group</strong> is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.<br /><br />The joint venture with Flou Read More

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

31st Mar 2014 10:35

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br />FTSE 100 - WINNERS<br /><br /><strong>Babcock</strong> International Group, up 3.5%. The company said its Cavendish Fluor Partnership has Read More

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

31st Mar 2014 08:33

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed Read More

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

26th Mar 2014 13:40

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of <strong>Lloyds Banking</strong> Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.< Read More

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

26th Mar 2014 11:30

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Standard Life</strong>, up 5.2%. The company has agreed to buy Ignis Asset Mana Read More

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

26th Mar 2014 11:03

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov Read More

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

24th Jan 2014 12:41

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.<br /><br />In a speech at the World Ec Read More

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

24th Jan 2014 11:01

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial Read More

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

24th Jan 2014 10:58

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide Read More

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

7th Jan 2014 08:22

Read More

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

31st Oct 2013 13:36

Read More

UK WINNERS & LOSERS: Hargreaves Continues To Rise, e-Therapeutics Trips

16th Oct 2013 11:57

Read More

e-Therapeutics Pretax Loss Widens As R&D Expenditure Rises

16th Oct 2013 08:56

Read More

FTSE 100 Latest
Value8,809.74
Change53.53